Wound Debridement Products Market Worth US$ 857.55 Bn by 2032 | FMI

In 2022, the wound debridement products market is anticipated to be worth US$ 497.3 billion. The overall demand for wound debridement products is anticipated to increase at a CAGR of 5.6% between 2022 and 2032, reaching approximately US$ 857.55 Billion by 2032 due to the rise in the incidence of hard and heal wounds, as …

Portable Oxygen Concentrators Market Expected to Witness a CAGR of 10.1% through 2022-2032

By the end of 2022, the global portable oxygen concentrators market is anticipated to reach US$ 1.9 billion, and it is projected to grow at a CAGR of 10.1% from 2022 to 2032. By 2032, market sales are anticipated to surpass US$ 5.0 Bn. Portable oxygen concentrators supply oxygen to patients suffering from respiratory diseases …

Ophthalmic Lasers Market to Display Impressive Growth of 5.4% with Rising Demand by 2022-2030

The global ophthalmic lasers market is anticipated to grow from a market value of US$ 884.3 Mn in 2022 to US$ 1.3 Bn by 2030, expanding at a moderate CAGR of 5.4%. Technological advancements have deeply penetrated every facet of the healthcare industry, and the ophthalmic lasers market growth is no exception. Over the years, ophthalmic disorders …

Pulmonology Devices Market– Global Industry Analysis and Deeper Insights | FMI

According to Future Market Insights (FMI), driven by the rising incidence of respiratory diseases the demand for pulmonology devices market will rise. Respiratory disorders such as asthma, chronic obstructive pulmonary disorder (COPD), and lung cancer is on the rise globally. Smoking and unhealthy living environment are often identified as common causes fuelling the incidence of respiratory disorders. …

Transradial Closure Devices Market Size to be worth USD 381.4 Mn by 2030

The transradial closure devices market is growing with the increasing cases of cardio vascular diseases all over the world. A new study by Future Market Insights (FMI) has projected the market to rise at 6.8% CAGR between 2022 and 2030. According to the report, demand will rise consistently on the back of surging cases of cardiovascular ailments …

Autoclaves Market Is Expected to reach USD 3.17 Bn by 2030

The global autoclaves market is estimated to be valued at US$ 2.09 Bn in 2022 and is expected to reach US$ 3.17 Bn by 2030, finds Future Market Insights (FMI) in a recent market survey. Gravity autoclave accounts for about 54.0% of the market value share of the product segment in 2021 According to the Centers for Disease Control and Prevention (CDC), on …

PD-L1 Biomarker Testing Market will reach a value of USD 1.46 Bn by 2032 at a CAGR of 9.4%

The global PD-L1 biomarker testing market size was valued at US$ 541.6 Mn in 2021 and is expected to exhibit a CAGR of close to 9.4% over the forecast period (2022-2032). Increasing incidence of cancer across the globe is underpinning the need for advanced cancer diagnosis equipment, which is expected to boost the market in …

Cell Culture Media Bags Market worth USD 2.67 Bn by 2030 at a CAGR of 10.8%

In its new market study, Future Market Insights (FMI) estimates global cell culture media bags market will register impressive growth between 2020 and 2030, progressing at a stellar CAGR of 10.8%. Furthermore, the study projects that the market will surge past a global valuation of US$ 2.67 Bn by 2030. The report attributes the growth of the market …

Foley Catheter Market Insights By Type, Industry, Application & End-User | FMI

Foley catheters  Market Size also known as urinary catheters, are flexible tubes that are passed through the urethra and bladder to facilitate easy drainage of urine. They are considered essential in the urology sector, aiding patients with bladder dysfunctions to drain urine into urine bags, and reducing urology-related complications. The prevalence of urological diseases – …

PD1/PDL1 Inhibitors Market Size to Reach USD 98.5 Bn by 2030 | CAGR of 10.7%

PD-1/PD-L1 Inhibitors market Share is among the highest growing field in the pharmaceutical industry. PD-1/PD-L1 Inhibitors promise improved survival of patients, with low toxicity which is a huge market driving factor. The products available in the market for PD-1/PD-L1 inhibitors are increasingly meeting safety standards and are effective in the treatment of cancers. However, experts believe …